Announcements

Welcome to the 6th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2015)

Published: 2015-09-16


The 6th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2015) will take place from October 23 to October 25, 2015 at the Regal Hotel in Shanghai, China. This important Conference will highlight the latest scientific and clinical developments related to the management of thymic malignancies and will bring together established scientists and clinicians from all over the world who have interest in the field of thymic cancers research. You could take a little bit of extra time to enjoy the beauty of Shanghai and its surroundings.

About ITMIG

“The mission of ITMIG is to promote the advancement of clinical and basic science pertaining to thymic and other mediastinal malignancies and related conditions. ITMIG is an academic organization that provides structure, organization and scientific rigor to research in these diseases. The primary goals of ITMIG are to provide infrastructure for international collaboration, promote a scientifically-based approach, and facilitate dissemination of knowledge about thymic malignancies and other mediastinal diseases, in order to improve the outcomes of people diagnosed with such a condition. ITMIG is a registered not-for profit organization.”

Highlights of the meeting

Overall Results of ChART Retrospective Database
Report of Ongoing or Recently Finished Studies
Overview of the Database and the Process for Analyses
Brief Recap of ITMIG Retrospective DB Analyses

Minimally Invasive Thymectomy (MIT):
Robot vs. VATS Thymectomy: Which One Do I Choose
Technical Aspects in VATS Thymectomy - Vincent Fang, USA

Update on the Global Asset Project - Frank Detterbeck, USA
Ongoing Clinical Trials - Heather Wakelee, USA
Outlier Analysis - Robert Korst, USA
Innovative Lecture on Outlier Analysis - Frank Detterbeck, USA

To provide the state-of the-art of thymic cancer, we are honored to work with Prof. Wentao Fang and Prof. Robert Korst on a Focused Issue on Management of Thymoma dedicated to the conference. The special issue will be published in Journal of Thoracic Disease (JTD) in the four quarter of 2015. Our Editors will also attend the conference and take the opportunity to communicate with our authors and readers. 

Below is the list of potential topics and suggested authors that would be covered in this Focused Issue:

1.Management of Thymic Malignancy Based on National Retrospective Database Studies - Consensus of the Chinese Alliance of Research for Thymomas 

Wentao Fang/ Shanghai Chest Hospital

2.The Enlightenments from ITMIG Consensus on WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined definitions, Histological Criteria, and Reporting 

Gang Chen/ Zhongshan Hospital, Shanghai

3.Induction Chemotherapy, Sequential and Concurrent Chemoradiation for Locally Advanced Thymic Tumors 

Changlu Wang/ Shanghai Chest Hospital

4.Thymectomy versus tumor resection for stage I and II thymic tumors 

Zhitao Gu/ Shanghai Chest Hospital

5.Adjuvant Chemotherapy for Stage I to III Thymic Tumors - the ChART Retrospective Database Analysis 

Yongtao Han/ Sichuan Cancer Hospital and Institute

6.Adjuvant Radiation for Stage III and IV Thymic Tumors - the ChART Retrospective Database Analysis 

Jianhua Fu/Sun Yat-sen University Cancer Center

7.Accuracy of Computed-Tomography in Evaluation of Clinical Staging and Resectability for Thymic Malignancy 

Yan Shen/ Shanghai Chest Hospital

8.Minimally Invasive Thymectomy for Thymic Tumors - the ChART Retrospective Database Analysis 

Lijie Tan/ Zhongshan Hospital, Shanghai

9.Verification of the ITMIG New Staging Proposal for Thymic Malignancy 

Yin Li/ Henan Cancer Hospital

10.Postoperative Survival for Patients with Thymoma Complicating Myasthenia Gravis - Retrospective Results of the ChART Database 

Liewen Pang/ Huashan Hospital, Shanghai

11.Preoperative Histological Diagnosis of Thymic Tumors - Results from the ChART Retrospective Database 

Zhentao Yu/ Tianjin Medical University Cancer Institute & Hospital

12.Induction therapies for advanced stage thymic tumors 

Yi Shen, Yucheng Wei

13.Clinico-pathological Analysis of 241 Thymic Epithelial Tumors--Experience in the Shanghai Chest Hospital from 1997-2004 

Lei Zhu, Jie Zhang/ Shanghai Chest Hospital


For more information about the meeting, please reference to: http://www.itmig2015.org/